Literature DB >> 30007560

Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction.

Connie W Tsao1, Asya Lyass2, Danielle Enserro3, Martin G Larson2, Jennifer E Ho4, Jorge R Kizer5, John S Gottdiener6, Bruce M Psaty7, Ramachandran S Vasan8.   

Abstract

OBJECTIVES: This study aimed to determine temporal trends in the incidence of and mortality associated with heart failure (HF) and its subtypes (heart failure with reduced ejection fraction [HFrEF] and heart rate with preserved ejection fraction [HFpEF]) in the community.
BACKGROUND: Major shifts in cardiovascular disease risk factor prevalence and advances in therapies may have influenced HF incidence and mortality.
METHODS: In the FHS (Framingham Heart Study) and CHS (Cardiovascular Health Study), for participants who were ≥60 years of age and free of HF (n = 15,217; 60% women; 2,524 incident HF cases; 115,703 person-years of follow-up), we estimated adjusted incidence rate ratios of HF, HFrEF, and HFpEF from 1990 to 1999 and 2000 to 2009. We compared the cumulative incidence of and mortality associated with HFrEF versus HFpEF within and between decades.
RESULTS: Across the 2 decades, HF incidence rate ratio was similar (p = 0.13). The incidence rate ratio of HFrEF declined (p = 0.0029), whereas HFpEF increased (p < 0.001). Although HFrEF incidence declined more in men than in women, men had a higher incidence of HFrEF than women in each decade (p < 0.001). The incidence of HFpEF significantly increased over time in both men and women (p < 0.001 and p = 0.02, respectively). During follow-up after HF, 1,701 individuals died (67.4%; HFrEF, n = 557 [33%]; HFpEF, n = 474 [29%]). There were no significant differences in mortality rates (overall, cardiovascular disease, and noncardiovascular disease) across decades within HF subtypes or between HFrEF and HFpEF within decade.
CONCLUSIONS: In several U.S. community-based samples from 1990 to 2009, we observed divergent trends of decreasing HFrEF and increasing HFpEF incidence, with stable overall HF incidence and high risk for mortality. Our findings highlight the need to elucidate factors contributing to these observations.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ejection fraction; epidemiology; heart failure; incidence; mortality; trends

Mesh:

Year:  2018        PMID: 30007560      PMCID: PMC6076350          DOI: 10.1016/j.jchf.2018.03.006

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  37 in total

1.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak?

Authors:  S Stewart; K MacIntyre; M M MacLeod; A E Bailey; S Capewell; J J McMurray
Journal:  Eur Heart J       Date:  2001-02       Impact factor: 29.983

4.  Trends in incidence, severity, and outcome of hospitalized myocardial infarction.

Authors:  Véronique L Roger; Susan A Weston; Yariv Gerber; Jill M Killian; Shannon M Dunlay; Allan S Jaffe; Malcolm R Bell; Jan Kors; Barbara P Yawn; Steven J Jacobsen
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

5.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

7.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

8.  Survival associated with two sets of diagnostic criteria for congestive heart failure.

Authors:  Gina D Schellenbaum; Thomas D Rea; Susan R Heckbert; Nicholas L Smith; Thomas Lumley; Veronique L Roger; Dalane W Kitzman; Herman A Taylor; Daniel Levy; Bruce M Psaty
Journal:  Am J Epidemiol       Date:  2004-10-01       Impact factor: 4.897

9.  Incidence and prevalence of heart failure in elderly persons, 1994-2003.

Authors:  Lesley H Curtis; David J Whellan; Bradley G Hammill; Adrian F Hernandez; Kevin J Anstrom; Alisa M Shea; Kevin A Schulman
Journal:  Arch Intern Med       Date:  2008-02-25

10.  Study of Cardiovascular Health Outcomes in the Era of Claims Data: The Cardiovascular Health Study.

Authors:  Bruce M Psaty; Joseph A Delaney; Alice M Arnold; Lesley H Curtis; Annette L Fitzpatrick; Susan R Heckbert; Barbara McKnight; Diane Ives; John S Gottdiener; Lewis H Kuller; W T Longstreth
Journal:  Circulation       Date:  2015-11-04       Impact factor: 29.690

View more
  62 in total

1.  Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry.

Authors:  Poghni A Peri-Okonny; Xiaojuan Mi; Yevgeniy Khariton; Krishna K Patel; Laine Thomas; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Nancy M Albert; Javed Butler; Adrian F Hernandez; Kevin McCague; Fredonia B Williams; Adam D DeVore; J Herbert Patterson; John A Spertus
Journal:  JACC Heart Fail       Date:  2019-02-06       Impact factor: 12.035

Review 2.  Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.

Authors:  Islam Y Elgendy; Dhruv Mahtta; Carl J Pepine
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

3.  Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.

Authors:  Alanna M Chamberlain; Cynthia M Boyd; Sheila M Manemann; Shannon M Dunlay; Yariv Gerber; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  Am J Med       Date:  2019-11-17       Impact factor: 4.965

4.  Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure.

Authors:  Roslyn A Prichard; Fei-Li Zhao; Julee Mcdonagh; Stephen Goodall; Patricia M Davidson; Phillip J Newton; Ben Farr-Wharton; Christopher S Hayward
Journal:  Qual Life Res       Date:  2021-01-02       Impact factor: 4.147

5.  Deliberating the Diagnostic Dilemma of Heart Failure With Preserved Ejection Fraction.

Authors:  Jennifer E Ho; Margaret M Redfield; Gregory D Lewis; Walter J Paulus; Carolyn S P Lam
Journal:  Circulation       Date:  2020-11-02       Impact factor: 29.690

6.  10-Year Risk Equations for Incident Heart Failure in the General Population.

Authors:  Sadiya S Khan; Hongyan Ning; Sanjiv J Shah; Clyde W Yancy; Mercedes Carnethon; Jarett D Berry; Robert J Mentz; Emily O'Brien; Adolfo Correa; Navin Suthahar; Rudolf A de Boer; John T Wilkins; Donald M Lloyd-Jones
Journal:  J Am Coll Cardiol       Date:  2019-05-21       Impact factor: 24.094

7.  Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.

Authors:  Ambarish Pandey; Muthiah Vaduganathan; Sameer Arora; Arman Qamar; Robert J Mentz; Sanjiv J Shah; Patricia P Chang; Stuart D Russell; Wayne D Rosamond; Melissa C Caughey
Journal:  Circulation       Date:  2020-06-03       Impact factor: 29.690

Review 8.  Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s).

Authors:  Nadia Bouabdallaoui; Anique Ducharme
Journal:  Curr Heart Fail Rep       Date:  2018-12

Review 9.  70-year legacy of the Framingham Heart Study.

Authors:  Charlotte Andersson; Andrew D Johnson; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2019-11       Impact factor: 32.419

10.  Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.

Authors:  Jasleen Ghuman; Xuan Cai; Ravi B Patel; Sadiya S Khan; Jonathan Hecktman; Margaret M Redfield; Gregory Lewis; Sanjiv J Shah; Myles Wolf; Tamara Isakova; Rupal Mehta
Journal:  J Card Fail       Date:  2020-10-07       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.